Literature DB >> 10992826

Influence of tramadol on the ventilatory response to hypoxia in humans.

P M Warren1, J H Taylor, K E Nicholson, P K Wraith, G B Drummond.   

Abstract

We studied the effect of tramadol on the ventilatory response to 7 min acute isocapnic hypoxia (SpO2 85.1 (SD 0.4)%) during steady mild hypercapnia (PE'CO2 0.7 kPa above normoxic baseline) in 14 healthy volunteers (seven male). The acute hypoxic response was measured before and 1 h after oral placebo or tramadol (100 mg). After tramadol, ventilation during mild hypercapnia (mean 11.28 litres min-1) was significantly less (P < 0.05) than during placebo baseline (13.93 litres min-1), tramadol baseline (14.63 litres min-1), or after placebo (14.95 litres min-1), confirming that tramadol has a small depressive effect on the hypercapnic ventilatory response. There was no significant difference in the hypoxic ventilation/SpO2 response (1 min-1 %-1) measured during the placebo baseline (0.99), placebo (1.18), tramadol baseline (0.78) or tramadol (0.68) runs. These data suggest that tramadol does not depress the hypoxic ventilatory response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992826     DOI: 10.1093/bja/85.2.211

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

Review 1.  Clinical pharmacology of tramadol.

Authors:  Stefan Grond; Armin Sablotzki
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Abuse liability and reinforcing efficacy of oral tramadol in humans.

Authors:  Shanna Babalonis; Michelle R Lofwall; Paul A Nuzzo; Anthony J Siegel; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2012-10-23       Impact factor: 4.492

3.  Is there a familial association between obstructive sleep apnoea/hypopnoea and the sudden infant death syndrome?

Authors:  M Vennelle; P E Brander; R N Kingshott; K Rees; P M Warren; J W Keeling; N J Douglas
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

4.  Chronic non-cancer pain: Focus on once-daily tramadol formulations.

Authors:  Flaminia Coluzzi; Consalvo Mattia
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.